Weon Kuu Chung
Overview
Explore the profile of Weon Kuu Chung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
171
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kim S, Chung H, Mai H, Nam Y, Shin S, Park Y, et al.
Int J Mol Sci
. 2020 Jul;
21(12).
PMID: 32630597
Alzheimer's disease (AD) is the most common type of dementia. AD involves major pathologies such as amyloid-β (Aβ) plaques and neurofibrillary tangles in the brain. During the progression of AD,...
12.
Kim S, Nam Y, Kim C, Lee H, Hong S, Kim H, et al.
Int J Mol Sci
. 2020 May;
21(10).
PMID: 32456197
Alzheimer's disease (AD) is the most common cause of dementia. The neuropathological features of AD include amyloid-β (Aβ) deposition and hyperphosphorylated tau accumulation. Although several clinical trials have been conducted...
13.
Chung E, Noh J, Lee K, Kim J, Chung W, Suh Y, et al.
Cancer Res Treat
. 2018 Oct;
51(3):1001-1010.
PMID: 30322229
Purpose: Lung Cancer Subcommittee of Korean Radiation Oncology Group (KROG) has recently launched a prospective clinical trial (KROG 17-06) of hippocampus-sparing whole brain radiotherapy (HS-WBRT) with simultaneous integrated boost (SIB)...
14.
Chung M, Kim D, Chung W, Lee S, Jeong S, Hwang J, et al.
Oncotarget
. 2017 Sep;
8(36):60479-60486.
PMID: 28947986
Purpose: To compare the clinical outcomes between short-course chemoradiotherapy (CRT) and long-course CRT with delayed surgery in locally advanced rectal cancer patients. Results: From 2010 to 2015, 19 patients were...
15.
Joh J, Lee B, Chun Y, Chung W, Lee H
J Vasc Surg Venous Lymphat Disord
. 2016 Jun;
4(3):336-9.
PMID: 27318054
Angiosarcoma is a rare soft tissue sarcoma of endothelial cell origin. It can arise from the endothelium of lymphatics (lymphangiosarcoma) or blood vessels (hemangiosarcoma). Chronic lymphedema of any origin is...
16.
Moon S, Yoon M, Chung M, Chung W, Kim D
Phys Med
. 2016 May;
32(5):657-63.
PMID: 27133139
In this paper, we report the results of our investigation into whole brain radiotherapy (WBRT) using linear accelerator-based intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in lung cancer...
17.
Han E, Paudel N, Sung J, Yoon M, Chung W, Kim D
Oncotarget
. 2016 Mar;
7(16):22960-9.
PMID: 27027239
The risk of secondary cancer from radiation treatment remains a concern for long-term breast cancer survivors, especially those treated with radiation at the age younger than 45 years. Treatment modalities...
18.
Song S, Ahn S, Chung W, Shin K, Choi E, Cho K
Radiat Oncol J
. 2015 Jul;
33(2):142-8.
PMID: 26157684
Purpose: To develop new on-line statistical program for the Korean Society for Radiation Oncology (KOSRO) to collect and extract medical data in radiation oncology more efficiently. Materials And Methods: The...
19.
Kim D, Chung K, Chung W, Bae S, Shin D, Hong S, et al.
Radiat Oncol
. 2014 Jun;
9:109.
PMID: 24886163
Purpose: To evaluate and compare the risks of secondary cancers from therapeutic doses received by patients with hepatocellular carcinoma (HCC) during intensity-modulated radiotherapy (IMRT), volumetric arc therapy (VMAT), and tomotherapy...
20.
Kim D, Chung W, Shin J, Lim Y, Shin D, Lee S, et al.
Radiat Oncol
. 2013 Jul;
8:182.
PMID: 23866307
Background: We measured and assessed ways to reduce the secondary neutron dose from a system for proton eye treatment. Methods: Proton beams of 60.30 MeV were delivered through an eye-treatment...